BioSpace News Archive

Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its fourth quarter and full year 2018 financial results will be released on Monday, February 4, after the market closes.

UroGen Pharma Ltd. today announced that it intends to offer and sell $150 million of its ordinary shares in an underwritten public offering.

Service Corporation International (NYSE: SCI) announced today that Michael R. Webb, SCI’s President and Chief Operating Officer, informed the company of his intent to retire, effective March 31, 2019.

An exclusive distribution agreement between Medline’s Respiratory Division and Southmedic is now making it possible for clinicians to access the latest breakthrough in advanced oxygen delivery technology in the OxyMask™ portfolio.

With this designation, CHI St. Luke’s Health-Memorial is now the highest accredited nationally recognized cardiovascular program in the region.

Roman Eagle Rehabilitation and Health Care Center, Inc. is proud to announce our recent investment in the Clorox® Total 360® System.

Quality Biomedical, the leading provider of biomedical equipment service and management software and solutions, today announced a complete integration with Brightree, a leading provider of cloud-based solutions helping post-acute care providers improve business performance and patient outcomes, to streamline workflows for home medical companies managing the service and deployment of biomedical equipment.

CVS Health today was recognized by FORTUNE magazine as one of the World’s Most Admired Companies for the fifth consecutive year.

The following is an open letter from Bahram Akradi, Founder, Chairman, and Chief Executive Officer of Life Time, Inc.

As fiducial markers gain traction in parallel to rising incidences of various cancer forms affecting lung, prostate, abdomen and kidney, the growth potential of the market is set to witness a considerable rise.